Nasus Pharma Ltd. NSRX shares are tumbling on Monday. The company announced topline results from its Phase 2 study of NS002, an investigational intranasal epinephrine powder formulation for the ...

The company's ability to hold off generic competitors long enough to develop a pair of replacement drugs for Humira that are ...

NRx Pharmaceuticals Inc. NRXP shares are surging on Monday following positive developments regarding its New Drug Application for NRX-100 (preservative-free intravenous ketamine). Ketamine is a ...

Bristol Myers Squibb has an attractive 4% yield and a strong dividend history.

The company's pipeline features almost 40 programs in late-stage clinical testing. These clinical trials are testing new drug candidates and seeking additional approvals for drugs such as Tremfya.

Acurx Pharmaceuticals Inc ACXP shares are trading sharply higher Wednesday afternoon despite a lack of company-specific news during the session. The move may reflect continued investor reaction to ...

In this article, we will be taking a look at the 7 Oversold Pharma Stocks to Buy Now. In 2024, the pharmaceutical sector in the United States was valued at $634.32 billion, and by 2030, it is expected ...

Over the next 5 years, Gland Pharma plans to invest approximately Rs 20 bn in capex, primarily towards BFS and ophthalmic ...